AI assistant
SILICON LABORATORIES INC. — Director's Dealing 2012
May 2, 2012
31118_dirs_2012-05-02_81c72db3-38eb-428a-bb25-0df0d7604ecd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SILICON LABORATORIES INC (SLAB)
CIK: 0001038074
Period of Report: 2012-04-28
Reporting Person: BRESEMANN DAVID P (Sr Vice President, Vertical)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.0001 par value | 67257 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $33.17 | 2014-08-10 | Common Stock, $0.0001 par value (1667) | Direct | |
| Non-Qualified Stock Option (right to buy) | $36.81 | 2015-12-19 | Common Stock, $0.0001 par value (3710) | Direct | |
| Non-Qualified Stock Option (right to buy) | $32.11 | 2017-02-15 | Common Stock, $0.0001 par value (11334) | Direct | |
| Non-Qualified Stock Option (right to buy) | $31.96 | 2018-02-15 | Common Stock, $0.0001 par value (15053) | Direct |
Footnotes
F1: Includes 27,464 restricted stock units (RSUs) that will entitle Reporting Person to receive one share of common stock per RSU. 12,881 RSUs will vest on February 15, 2013, 8,747 RSUs will vest on February 15, 2014, and 5,836 RSUs will vest on February 15, 2015. All RSUs will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan.
F2: Option vests and becomes exercisable with respect to (i) twenty percent (20%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of forty-eight (48) successive monthly installments over the forty-eight (48) month period measured from the date exercisable.
F3: Option vests and becomes exercisable with respect to (i) twenty-five percent (25%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of thirty-six (36) successive monthly installments over the thirty-six (36) month period measured from the date exercisable.